Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons

Insights

Monoamine oxidase A (MAO-A) is primarily intrasynaptosomal in rat noradrenaline and dopamine systems. Selective MAO-A inhibitors and a metabolite of a MAO-B inhibitor reduce locus coeruleus neuronal firing.

Area of Science:

  • Neuropharmacology
  • Enzymology
  • Neuroscience

Background:

  • Monoamine oxidase (MAO) enzymes are crucial for neurotransmitter metabolism.
  • Understanding the localization and inhibition of MAO subtypes is vital for neurological drug development.
  • The noradrenaline system, particularly the locus coeruleus (LC), plays a key role in regulating neuronal activity.

Purpose of the Study:

  • To investigate the intrasynaptosomal localization of MAO-A and MAO-B in rat brain noradrenaline and dopamine systems.
  • To examine the effects of selective MAO inhibitors on noradrenergic intrasynaptosomal MAO activity.
  • To assess the impact of these inhibitors on the neuronal firing rate of noradrenaline-containing cells in the locus coeruleus.

Main Methods:

  • Utilized a specific "low substrate concentration technique" to measure intrasynaptosomal MAO-A and MAO-B activities.
  • Administered selective MAO inhibitors (clorgyline, (+)-FLA 336, pargyline, (-)-deprenyl) and an enzyme inhibitor (SK&F 525 A) to rats.
  • Recorded spontaneous firing rates of locus coeruleus (LC) neurons.

Main Results:

  • Intrasynaptosomal MAO activity in rat brain noradrenaline and dopamine systems was predominantly MAO-A, with MAO-B contributing less than 15%.
  • Selective MAO-A inhibitors (clorgyline, (+)-FLA 336) significantly reduced LC neuronal firing rate by 40%.
  • (-)-Deprenyl, a selective MAO-B inhibitor, also suppressed LC neuronal firing, an effect blocked by SK&F 525 A, suggesting mediation by a metabolite like l-amphetamine.

Conclusions:

  • Intrasynaptosomal MAO in noradrenaline and dopamine systems is mainly MAO-A, potentially reflecting innervation density.
  • Selective MAO-A inhibition profoundly impacts noradrenergic neuronal activity in the locus coeruleus.
  • The MAO-B inhibitor (-)-deprenyl exerts its inhibitory effect on LC neurons via a metabolite, not directly.